Suppr超能文献

给药途径对新型支气管扩张剂双甲苯喘定在大鼠体内代谢及排泄的影响。

The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.

作者信息

Aimoto T, Ito O, Kimura R, Murata T, Ito K

出版信息

Xenobiotica. 1979 Mar;9(3):173-80. doi: 10.3109/00498257909038718.

Abstract
  1. [3H]Bitolterol, an ester prodrug to colterol (N-t-butyl-arterenol), when administered orally, was excreted mostly in the urine; approx. equal amounts of 3H were found in urine and faeces after intraperitoneal or intravenous injection. 2. Half the dose was excreted in the bile following parenteral administration, while only a small amount of radioactivity was found in bile after oral dosage. The biliary-excreted material consisted mainly of glucuronides, for all routes of administration. 3. The glucuronides of colterol and 3-O-methyl-colterol were excreted in urine after oral administration of bitolterol. In addition to the glucuronides, free colterol and 3-O-methyl-colterol were excreted in urine following parenteral administration. 4. A part of bitolterol was hydrolysed to colterol in rat stomach, and bitolterol was more rapidly hydrolysed to colteral with homogenates of intestinal mucosa than with stomach homogenates in vitro.
摘要
  1. [3H]比托特罗是可待特罗(N-叔丁基肾上腺素)的酯前体药物,口服给药后,大部分经尿液排泄;腹腔注射或静脉注射后,尿液和粪便中发现的3H量大致相等。2. 肠胃外给药后,一半剂量经胆汁排泄,而口服给药后胆汁中仅发现少量放射性物质。无论采用何种给药途径,经胆汁排泄的物质主要为葡糖醛酸苷。3. 口服比托特罗后,可待特罗和3-O-甲基可待特罗的葡糖醛酸苷经尿液排泄。除葡糖醛酸苷外,肠胃外给药后,游离的可待特罗和3-O-甲基可待特罗也经尿液排泄。4. 比托特罗的一部分在大鼠胃中水解为可待特罗,在体外,与胃匀浆相比,比托特罗在肠黏膜匀浆中更迅速地水解为可待特罗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验